UBE2C and nonpapillary renal cell carcinoma: Recent evidence has identified Ubiquitin conjugating enzyme E2 C (UBE2C) as a pathological stage-relevant gene, which is associated with carcinogenesis and progression in ccRCC, and may provide potential diagnostic, therapeutic and prognostic biomarkers for ccRCC [20].